In Vitro Neutralization of Omicron Variant Serum from vaccinated persons was assayed for
ability to neutralize the omicron variant of SARS-CoV-2. Persons who had received two doses …

Convalescent Antibodies after Omicron Infection Although considerable data show cross-reactivity
among antibodies generated by infection with the various SARS-CoV-2 variants of …

Neutralizing antibodies are a major correlate of protection for many viruses including the
novel coronavirus SARS-CoV-2. Thus, vaccine candidates should potently induce neutralizing …

Background In recent months numerous health care professional acquired COVID-19 at the
workplace resulting in significant shortages in medical and nursing staff. We investigated …

Recently, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.529
(Omicron) has been described. Here, we analyze titers of neutralizing antibodies of sera …

The severe‐acute‐respiratory‐syndrome‐coronavirus‐2 (SARS‐CoV‐2) is the causative
agent of COVID‐19, but host cell factors contributing to COVID‐19 pathogenesis remain only …

Background & Aims The coronavirus disease 2019 (COVID-19) pandemic has affected
populations, societies, and lives for more than 2 years. Long-term sequelae of COVID-19, …

Several studies have shown that SARS-CoV-2 BA.1 omicron is an immune escape variant.
Meanwhile, however, omicron BA.2 and BA.5 became dominant in many countries and …

Objectives To evaluate the restart of the German Bundesliga (football (soccer)) during the
COVID-19 pandemic from a medical perspective. Methods Participants were male professional …

Since emergence of the initial SARS-CoV-2 BA.1, BA.2 and BA.5 variants, Omicron has
diversified substantially. Antigenic characterization of these new variants is important to analyze …